CFLT — Confluent Income Statement
0.000.00%
Last trade - 00:00
- $7.75bn
- $6.93bn
- $776.95m
- 76
- 12
- 84
- 58
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 150 | 237 | 388 | 586 | 777 |
Cost of Revenue | |||||
Gross Profit | 100 | 161 | 251 | 384 | 547 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 248 | 470 | 727 | 1,049 | 1,256 |
Operating Profit | -98.1 | -233 | -340 | -463 | -479 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -95 | -230 | -340 | -446 | -407 |
Provision for Income Taxes | |||||
Net Income After Taxes | -95 | -230 | -343 | -453 | -443 |
Net Income Before Extraordinary Items | |||||
Net Income | -95 | -230 | -343 | -453 | -443 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -95 | -230 | -343 | -453 | -443 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.376 | -0.91 | -1.26 | -1.62 | -1.4 |
Dividends per Share |